Signal from the log
Coherence Neuro
45 M$ · Series A · United States · Medtech
Coherence Neuro, née de deux chercheurs rencontrés à l'université de Cambridge, développe un implant cérébral de la taille d'un bouton qui enregistre l'activité électrique autour d'une tumeur pour suivre le cancer en continu, et à terme le traiter par stimulation. Le premier essai visé est le glioblastome.
Article
Announced on , logged by the watch of 28 October 2026.
- Operation
- Funding round
- Announced amount
- 45 M$
- Stage
- Series A
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Founders Fund , OpenAI Startup Fund , with Lux Capital , 8VC , Timeless , Olive Capital , Ahren
Provenance
Source pulse2
Logged on 28 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.